Ò©Àí»îÐÔ: Antiarrhythmic £¨rat arrhythmia caused by BaCl2£©;inhibits fatigue; antiviral; inhibits replication of HSV-1; bidirectional action to blood pressure £¨mus, first increases £ánd then lowers blood pressure, whileheart rate slows£©; calcium antagonist; increases blood pressure £¨injecting0.3μL into lateral area of rat hypothalamus, average arteriotony noticeablyrising£©; antioxidant £¨rat hepatic homogenate, caused by H2O2, IC50 =644.8μg/mL£©; cAMP phosphodiesterase inhibitor £¨in vitro, IC50 = 137μmol/L£©;antihypercholesterolemic £¨reduces the level of cholesterol in serum£©; promotesbiosynthesis of DNA, protein £ánd lipid £¨murine marrow cells£©; enhancescytotoxic effects of daunomycin £ánd vincaleucoblastine; promotes plasma

secretion of corticosterone £¨ED50 = 112μmol/kg£©; liver £ánd nerve protectant;reduces uterine contraction £¨gpg, in vitro, caused by acetylcholine£©;vasodilator £¨dog£©; anti-inflammatory £¨modulator of cytokine network: inhibits IC50 = 56.5μmol/Land 51.3μmol/L, respectively£©; antinociception £¨i.t.injected 0.7μg substance P-induced pain model, EC = 50μg i.t.£©; neurite

outgrowth enhancer £¨hmn neuroblastoma SK-N-SH cells, 100μmol/L, total length of neurites = 149.3μm, number of varicosity per cell = 0.93, p<0.05;control, total length of neurites = 45.3μm, number of varicosity per cell =0.10£©; hepatoprotective £¨inhibits activation of macrophages, inhibitsincrease in sALT £ánd sAST levels, in vivo, D-GalN/LPS-induced liver injury in mouse, 100mg/kg ip for sALT, InRt = 33%; 100mg/kg ip for sAST, InRt =40%; control Hydrocortisone, 20mg/kg ip for sALT, InRt = 99%; 20mg/kg ipfor sAST, InRt = 97%£©.